[Event Report] The Second Meeting of Working Group 5 on Vaccine Research and Development, “The Next Actions to Ensure the Development and Implementation of Immunization and Vaccine Policies” (January 17, 2022)
date : 1/28/2022
Tags: Vaccinations
On January 17, 2022, Health and Global Policy Institute (HGPI) held the second meeting of Working Group 5 on vaccine research and development for “Next Actions for the Development and Implementation of Immunization and Vaccination Policies.”
This meeting was the second working group meeting on the R&D and production pipeline and, based on points raised at the previous meeting, examined the next steps needed to reinforce the vaccine R&D and production pipeline in the future. A multi-stakeholder group of experts in the field deepened discussions on the pharmaceutical regulation system for vaccines and the ability of the vaccine R&D and production systems, which are undergoing rapid investigation during the ongoing Coronavirus Disease 2019 (COVID-19) pandemic, to provide leadership and coordination.
To prevent the potential spread of COVID-19, this meeting was held online using a remote conferencing system.
■2021 Advisory Board Working Group 5 (Titles omitted; in alphabetical order by last name)
Members:
Ken J. Ishii (Professor, Division of Vaccine Science, Institute of Medical Science, The University of Tokyo/ Director, International Vaccine Design Center, Institute of Medical Science)
Masayuki Imagawa (Chief Executive, Japan Vaccine Industry Association/ Vice President & Head, Japan Vaccine Business Unit, Takeda Pharmaceutical Co., Ltd.)
Hiroshi Kasanuki (Specially Appointed Professor, Waseda University/ Advisor, Institute for Medical Regulatory Science, Waseda University)
Kengo Sonoda (General Manager, Development Department, R&D Division, KM Biologics Co., Ltd.)
Hideki Hasegawa (Director, Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases)
Yoshiharu Matsuura (Director, Center for Infectious Disease Education and Research (CiDER))
Shinji Matsumoto (Chair, Vaccines Working Team, EFPIA Japan)
Isao Miyairi (Professor, Faculty of Pediatrics, Hamamatsu University School of Medicine)
Yoshiaki Yamagishi (Associate Professor, Medical Center of Translational Research, Department of Medical Innovation, Osaka University)
Observer:
Yasuhiro Araki (Director, Office of Vaccine and Blood Products, Pharmaceuticals and Medical Devices Agency)
MC/Moderator
Takahiro Sakauchi (Associate, Health and Global Policy Institute)
Event Overview
Joji Sugawara (Manager, Health and Global Policy Institute)
■Related contents held as part of the project
– November 4, 2021 The First Meeting of Working Group 5 on Vaccine Research and Development, “Next Actions for the Development and Implementation of Immunization and Vaccination Policies”
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)